Acorn is currently enrolling patients in an investigational study involving patients with Heart Failure. This study is being conducted at 9 sites in the United States and Canada. For further information regarding our clinical study click here.
Patients and their friends and/or family members should to talk with their physician or healthcare provider regarding heart failure therapy options best suited to their medical needs. Healthcare providers trained on indications and application of CorCap Cardiac Support Device therapy are best able to determine whether a patient might be a candidate for this treatment. All Acorn clinical study sites have extensive experience managing patients with Heart Failure and determining if participating in an Acorn study is an appropriate therapy option.
Physicians, nurses, and other healthcare providers seeking information regarding CorCap CSD therapy, active CorCap CSD implanting sites, and/or associated clinical trials may reference the Healthcare Provider section of our website or contact Acorn Cardiovascular for additional information.
Please note that the CorCap Cardiac Support Device is for investigational use only in the North America and European Union.
|
